Space humbles the SEAL-doctor-astronaut
When you buy through links on our articles, Future and its syndication partners may earn a commission.
With this week's (June 9 through June 13) expected arrival of a visiting crew delayed just before their launch, science and maintenance work on board the International Space Station was lighter than usual. The Expedition 73 crew had time to reflect on their maintenance work and mark personal and national milestones during their seventh week in orbit.
"Space is one of the most humbling environments I've operated in," said Expedition 73 flight engineer Jonny Kim, who before becoming a NASA astronaut was a U.S. Navy SEAL and a medical doctor.
Kim on Thursday (June 12) wrote on social media about his experience working behind the International Space Station's refrigerator-size science racks to clean air filters, examine seals and swap out chipsets for the laboratory's network servers. Even with the help of Mission Control keeping an eye on his work through live video views, it can be difficult to keep track of all of the parts, Kim found.
"One thing I've come to appreciate with maintenance in space is how much gravity helps keep things where they belong. For example, on the ground, I can simply set my pliers down and I know they won't disappear. But in space, we have to think before every action, because setting pliers down is a recipe for losing them," he wrote.
Among the research that was conducted aboard the space station this week was:
Ultrasound 2 — Anne McClain and Nichole Myers with NASA joined Expedition 73 commander Takuya Onishi of the Japan Aerospace Exploration Agency (JAXA) to use this biomedical device to undergo their first set of eye exams. Working with a doctor on the ground, the scans were to determine if the astronauts' time in space has affected the structure of their eyes.
Solid Combustion Experiment Module — Onishi also replaced the sample cartridges for an ongoing fire experiment in Japan's Kibo laboratory, which is aimed at improving the safety of spacecraft and anywhere else astronauts may live when off Earth.
Flight engineer Kirill Peskov of the Russian space agency Roscosmos continued setting up cameras to capture landmarks across Asia and Europe while fellow cosmonaut Alexey Zubritskiy set up equipment to measure neutron radiation caused by solar flares and gamma-ray bursts in an effort to learn if there is an affect on spacecraft.
In addition to Kim's work on swapping out air filters and chipsets, the crew also devoted time to maintaining the space station's systems, including:
Enhanced European Exploration Exercise Device (E4D) — Onishi and Kim added grease to the apparatus that is being assessed for its possible use on future missions to the moon. The E4D provides crew members with the same type of exercises as if they were bicycling, rowing and using resistive devices, such as rope pulling and climbing.
Waste and Hygiene Compartment — Working in the Tranquility Node 3 module, McClain drained the tanks for the U.S. segment's bathroom.
Extravehicular Mobility Unit (EMU) — Inside the Quest airlock, Ayers serviced one of the U.S. spacesuits. She then cleaned and documented the metal oxide containers that are used to scrub carbon dioxide from the extravehicular mobility unit (EMU) during spacewalks.
Other work included monitoring the station's decibel levels, checking the station's water quality and clearing the vents of floating debris.
Expedition 73 flight engineer and NASA astronaut Anne McClain marked two birthdays this week.
First, on Saturday (June 7) she celebrated her own 46th revolution around the sun. Here she displays cards, gifts and a cake presented to her by her crewmates. Happy birthday, Anne!!
Then on Thursday (June 12), she spoke with Dan Driscoll. Secretary of the U.S. Army, to mark the 250th anniversary of the Army's founding. McClain is an active colonel in the service.
"Thank you for your service to the Army and for all our soldiers out there celebrating our 250th birthday of our incredible United States Army, thank you for your service," she said. "I am proud to represent the Army, which is really an army of innovators, leaders and problem solvers."
Ryzhikov began the week inspecting hatch seals in the space station's Russian segment. That work further informed an ongoing concern about air leaks emanating from Roscosmos' Zvezda service module.
While the leak has been halted, NASA and Axiom Space decided on Thursday (June 12) to stand down from the launch of the Axiom Mission 4 (Ax-4) crew to give more time to consider additional fixes aboard the station.
A new launch date for former astronaut Peggy Whitson with a crew of three astronauts from India, Hungary and Poland is still to be determined.
As of Friday (June 13), there are 7 people aboard the International Space Station: commander Takuya Onishi of JAXA, Anne McClain, Nichole Ayers and Jonny Kim of NASA and Kirill Peskov, Sergey Ryzhikov and Alexey Zubritsky of Roscosmos, all flight engineers.
There are two docked crew spacecraft: SpaceX's Dragon "Endurance" attached to the forward port of the Harmony module, and Roscosmos' Soyuz MS-27 attached to the Earth-facing port of the Prichal node.
There are also two docked cargo spacecraft: Roscosmos' Progess MS-29 (90P) attached to the space-facing port of the Poisk module and Progress MS-30 (91P) attached to the aft port of the Zvezda service module.
As of Friday, the space station has been continuously crewed for 24 years, 7 months and 12 days.
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
32 minutes ago
- Yahoo
How do painkillers actually kill pain? From ibuprofen to fentanyl, it's about meeting the pain where it's at
Without the ability to feel pain, life is more dangerous. To avoid injury, pain tells us to use a hammer more gently, wait for the soup to cool or put on gloves in a snowball fight. Those with rare inherited disorders that leave them without the ability to feel pain are unable to protect themselves from environmental threats, leading to broken bones, damaged skin, infections and ultimately a shorter life span. In these contexts, pain is much more than a sensation: It is a protective call to action. But pain that is too intense or long-lasting can be debilitating. So how does modern medicine soften the call? As a neurobiologist and an anesthesiologist who study pain, this is a question we and other researchers have tried to answer. Science's understanding of how the body senses tissue damage and perceives it as pain has progressed tremendously over the past several years. It has become clear that there are multiple pathways that signal tissue damage to the brain and sound the pain alarm bell. Interestingly, while the brain uses different pain signaling pathways depending on the type of damage, there is also redundancy to these pathways. Even more intriguing, these neural pathways morph and amplify signals in the case of chronic pain and pain caused by conditions affecting nerves themselves, even though the protective function of pain is no longer needed. Painkillers work by tackling different parts of these pathways. Not every painkiller works for every type of pain, however. Because of the multitude and redundancy of pain pathways, a perfect painkiller is elusive. But in the meantime, understanding how existing painkillers work helps medical providers and patients use them for the best results. A bruise, sprain or broken bone from an injury all lead to tissue inflammation, an immune response that can lead to swelling and redness as the body tries to heal. Specialized nerve cells in the area of the injury called nociceptors sense the inflammatory chemicals the body produces and send pain signals to the brain. Common over-the-counter anti-inflammatory painkillers work by decreasing inflammation in the injured area. These are particularly useful for musculoskeletal injuries or other pain problems caused by inflammation such as arthritis. Nonsteroidal anti-inflammatories like ibuprofen (Advil, Motrin), naproxen (Aleve) and aspirin do this by blocking an enzyme called COX that plays a key role in a biochemical cascade that produces inflammatory chemicals. Blocking the cascade decreases the amount of inflammatory chemicals, and thereby reduces the pain signals sent to the brain. While acetaminophen (Tylenol), also known as paracetamol, doesn't reduce inflammation as NSAIDs do, it also inhibits COX enzymes and has similar pain-reducing effects. Prescription anti-inflammatory painkillers include other COX inhibitors, corticosteroids and, more recently, drugs that target and inactivate the inflammatory chemicals themselves. Because inflammatory chemicals are involved in other important physiological functions beyond just sounding the pain alarm, medications that block them will have side effects and potential health risks, including irritating the stomach lining and affecting kidney function. Over-the-counter medications are generally safe if the directions on the bottle are followed strictly. Corticosteroids like prednisone block the inflammatory cascade early on in the process, which is probably why they are so potent in reducing inflammation. However, because all the chemicals in the cascade are present in nearly every organ system, long-term use of steroids can pose many health risks that need to be discussed with a physician before starting a treatment plan. Many topical medications target nociceptors, the specialized nerves that detect tissue damage. Local anesthetics, like lidocaine, prevent these nerves from sending electrical signals to the brain. The protein sensors on the tips of other sensory neurons in the skin are also targets for topical painkillers. Activating these proteins can elicit particular sensations that can lessen the pain by reducing the activity of the damage-sensing nerves, like the cooling sensation of menthol or the burning sensation of capsaicin. Because these topical medications work on the tiny nerves in the skin, they are best used for pain directly affecting the skin. For example, a shingles infection can damage the nerves in the skin, causing them to become overactive and send persistent pain signals to the brain. Silencing those nerves with topical lidocaine or an overwhelming dose of capsaicin can reduce these pain signals. Nerve injuries, most commonly from arthritis and diabetes, can cause the pain-sensing part of the nervous system to become overactive. These injuries sound the pain alarm even in the absence of tissue damage. The best painkillers in these conditions are those that dampen that alarm. Antiepileptic drugs, such as gabapentin (Neurontin), suppress the pain-sensing system by blocking electrical signaling in the nerves. However, gabapentin can also reduce nerve activity in other parts of the nervous system, potentially leading to sleepiness and confusion. Antidepressants, such as duloxetine and nortriptyline, are thought to work by increasing certain neurotransmitters in the spinal cord and brain involved in regulating pain pathways. But they may also alter chemical signaling in the gastrointestinal tract, leading to an upset stomach. All these medications are prescribed by doctors. Opioids are chemicals found or derived from the opium poppy. One of the earliest opioids, morphine, was purified in the 1800s. Since then, medical use of opioids has expanded to include many natural and synthetic derivatives of morphine with varying potency and duration. Some common examples include codeine, tramadol, hydrocodone, oxycodone, buprenorphine and fentanyl. Opioids decrease pain by activating the body's endorphin system. Endorphins are a type of opioid your body naturally produces that decreases incoming signals of injury and produces feelings of euphoria – the so-called 'runner's high.' Opioids simulate the effects of endorphins by acting on similar targets in the body. Although opioids can decrease some types of acute pain, such as after surgery, musculoskeletal injuries like a broken leg or cancer pain, they are often ineffective for neuropathic injuries and chronic pain. Because the body uses opioid receptors in other organ systems like the gastrointestinal tract and the lungs, side effects and risks include constipation and potentially fatal suppression of breathing. Prolonged use of opioids may also lead to tolerance, where more drug is required to get the same painkilling effect. This is why opioids can be addictive and are not intended for long-term use. All opioids are controlled substances and are carefully prescribed by doctors because of these side effects and risks. Although cannabis has received a lot of attention for its potential medical uses, there isn't sufficient evidence available to conclude that it can effectively treat pain. Since the use of cannabis is illegal at the federal level in the U.S., high-quality clinical research funded by the federal government has been lacking. Researchers do know that the body naturally produces endocannabinoids, a form of the chemicals in cannabis, to decrease pain perception. Cannabinoids may also reduce inflammation. Given the lack of strong clinical evidence, physicians typically don't recommend them over FDA-approved medications. While sounding the pain alarm is important for survival, dampening the klaxon when it's too loud or unhelpful is sometimes necessary. No existing medication can perfectly treat pain. Matching specific types of pain to drugs that target specific pathways can improve pain relief, but even then, medications can fail to work even for people with the same condition. More research that deepens the medical field's understanding of the pain pathways and targets in the body can help lead to more effective treatments and improved pain management. This article is republished from The Conversation, a nonprofit, independent news organization bringing you facts and trustworthy analysis to help you make sense of our complex world. It was written by: Rebecca Seal, University of Pittsburgh and Benedict Alter, University of Pittsburgh Read more: How do drugs know where to go in the body? A pharmaceutical scientist explains why some medications are swallowed while others are injected What is fentanyl and why is it behind the deadly surge in US drug overdoses? A medical toxicologist explains Sepsis is one of the most expensive medical conditions in the world – new research clarifies how it can lead to cell death Rebecca Seal receives funding from National Institutes of Health Benedict Alter receives funding from National Institutes of Health, Foundation for Anesthesia Education and Research, and the International Anesthesia Research Society.
The Hill
36 minutes ago
- The Hill
After the Trump-Musk dustup, NASA has much to consider
The social media-driven feud between President Donald Trump and SpaceX CEO Elon Musk may have simmered down a bit, with the rhetoric cooling and Musk even deleting some of his ill-considered posts about Trump from X and then apologizing for them. But the shockwaves generated by the tit-for-tat insults and threats still reverberate through NASA and the commercial space sector. When Trump threatened to pull all of SpaceX's government contracts and Musk responded by threatening to decommission the Dragon spacecraft, an apocalyptic scenario that would have cripped NASA loomed. Fortunately, both men have since backed off. Even so, according to the Washington Post, NASA and the Defense Department are quietly urging commercial space companies to hurry the development of hardware that can compete with what SpaceX has to offer. Encouraging competition with SpaceX is sound policy regardless of the relationship between Trump and Musk. However, that competition is months, if not years, in the future. The next flight of the Boeing Starliner, which failed so spectacularly in 2024, will be early next year at the earliest. The Blue Origin New Glenn, an answer to the SpaceX Falcon family of rockets, may launch once more this year and is a long way from achieving Falcon-level launch cadence. It is in Trump's and Musk's interests, and that of the American space effort, that both men repair their relationship and move on. One of the issues that drove Trump and Musk apart was Trump's abrupt and inexplicable withdrawal of the nomination of Jared Isaacman, a billionaire entrepreneur and private space traveler, for NASA administrator. Musk had championed Isaacman, who is well regarded in the aerospace community, and took it to heart when Trump changed his mind about his own nominee. The resulting leadership vacuum at NASA is being filled by Congress. The Senate Commerce Committee, chaired by Sen. Ted Cruz (R-Texas), has offered its own ideas for a NASA budget. The Senate Commerce document is at odds with the White House proposal in one important aspect. Whereas the Trump budget eliminates the Space Launch System after Artemis III and the Lunar Gateway, Senate Commerce would retain the massive, expensive rocket at least through Artemis V and would build the Gateway to support future Artemis missions. A NASA administrator such as Isaacman would be able to argue for the White House's approach. As for Isaacman, some people in the MAGA world, no doubt stung by the near-universal outrage sparked by his treatment at the hands of the White House, have started to trash the former nominee in the media. A recent Daily Caller story quoted unnamed White House officials accusing Isaacman of not only giving money to Democrats but of supporting diversity, equity and inclusion initiatives at his companies and in his private spaceflights. But both of these facts were known when Isaacman was nominated. According to the story, the officials said, 'Isaacman would have been a black spot on an administration otherwise filled with Republican Trump supporters or, at least, individuals like Robert F. Kennedy Jr. who backed the president prior to the election.' To hear these unnamed sources talk, Isaacman is no better than left-wing House members Rep. Alexandria Ocasio-Cortez (D-N.Y.), Rep. Ilhan Omar (D-Minn.) and their Squad. It should be noted that even if Isaacman wanted to impose DEI policies at NASA, he couldn't because of Trump's executive order prohibiting it across the federal government. Isaacman posted to X in his own defense: 'I am a moderate and donated to both parties for different reasons … my largest contribution was to President Trump — because I support many of his policies. I definitely did not like the direction this country was going over the last 4 years.' He went on to state, 'I have never spoken against the President. I have never voted against him.' It sounds like Isaacman is very loyal to Trump, remarkable under the circumstances. The suggestion of disloyalty is spurious and against the White House's interests. Isaacman's situation could provide the basis of a rapprochement between Trump and Musk. Musk has already apologized to the president for some of his posts on X, particularly the one suggesting that Trump is named in the Department of Justice's files on Jeffrey Epstein. But the president should admit fault as well. He was deceived by some of his staff about Isaacman's character. If it is not too late, he should reverse himself a second time and send his fellow billionaire's name back into nomination. NASA, the U.S., and the Trump-Musk partnership would gain as a result. Mark R. Whittington, who writes frequently about space policy, has published a political study of space exploration entitled 'Why is It So Hard to Go Back to the Moon?' as well as 'The Moon, Mars and Beyond,' and, most recently, 'Why is America Going Back to the Moon?' He blogs at Curmudgeons Corner.
Yahoo
2 hours ago
- Yahoo
‘People didn't like women in space': how Sally Ride made history and paid the price
A week before Sally – a documentary about the first American woman to fly into space – landed at the Sundance film festival in January, Nasa employees received emails informing them how Donald Trump's diversity, equity and inclusion (DEI) rollbacks would take effect. Contracts and offices associated with DEI programs were to be terminated. Staff were given Orwellian instruction to inform the government of any attempt to disguise inclusion efforts in 'coded or imprecise language'. In the weeks to follow, Nasa would take back its promise to send the first woman and person of color to the moon's surface. Meanwhile, employees are reported to be hiding their rainbow flags and any other expressions of solidarity with the LGBTQ+ community, allegedly because they were instructed to do so though Nasa denies those claims. 'The pride flag flew in space a couple years ago,' says Cristina Costantini, the director of Sally, on a Zoom call with the Guardian. 'Now all Nasa employees are being asked to take down any representations of pride.' Related: 'Absolutely shocking': Netflix documentary examines how the Titan sub disaster happened Costantini calls the developments sad, especially because such harmful silencing contributes to the very atmosphere that made her film's subject hide her own queer identity throughout her celebrated career. Sally Ride, who made history when she rode the space shuttle Challenger into the stars on 18 June 1983, was a lesbian. The public, and so many who knew Ride personally, only found out that part of her legacy after she died of cancer in 2012. Ride's obituary identified Tam O'Shaughnessy as her partner of 27 years. O'Shaughnessy is a key voice in Sally, a National Geographic documentary revisiting everything we thought we knew about Ride – from her astronomic accomplishments to the infuriating sexism she confronted at Nasa and in the media, with reporters questioning how she would dress, whether space travel would affect her ovaries and if she would buckle and cry in the face of daunting challenges. But now there's the extra dimension, the part of Ride kept tragically buried because of the institutionalized homophobia we see resurfacing today. 'We made this movie not thinking it was particularly controversial,' says Costantini. 'We had no idea it would be this relevant.' Costantini is speaking from her Los Angeles office in Atwater Village, a photo of a space shuttle and another of Ride on the Challenger mission hovering just behind her. The investigative reporter turned film-maker – who grew up wanting to be a scientist and made her feature debut co-directing the Sundance audience award winner Science Fair – describes Ride as a major influence on her life. She remembers researching the astronaut as a young child on an old Encarta Encyclopedia CD-Rom for a book report. In grade three, Costantini contributed to a class mural where the students in her Milwaukee school painted their heroes on a wall. Ride is drawn standing alongside Brett Favre and Michael Jordan – a small sampling of the heroes that fed childhood aspirations in the mid-90s, says Costantini. With Sally, Costantini is returning to her icon's story with a canvas bigger than either a book report or mural, but an even more challenging story to tell. 'The film is really two stories interwoven,' says Costantini. 'It's the public and the private Sally. The public Sally is so well-documented that it's a problem. We had to bring in 5,000 reels from the Nasa archive and sort through and sound sync all of them. That was a monumental task. 'And then the other task is the private story, maybe the more interesting story, which has no documentation at all. There are only five really good pictures of [Sally and her partner, Tam] together that we had. You can't build a love story out of showing people the same five pictures over and over again. For that we had to kind of invent our own cinematic romantic language.' Costantini's doc pairs narrations from O'Shaughnessy and others who were close to Ride with animation and 16mm visuals. They express the love, the excitement of first relationships, the heavy toll from keeping these feelings secret and the sting when Ride – whose noted emotional reserve is making more and more sense – would behave inexplicably. 'Sally is a very confusing central subject in some ways,' says Costantini, remarking on how Ride didn't always make for a picture-perfect feminist hero, the uneasiness going a long way to make her even more compelling. The director refers to a story recounted by fellow astronaut Kathryn Sullivan. During the race to become the first American woman to go to space, Ride sabotaged a Nasa exercise Sullivan was working on. Talking heads mull whether that was an example of Ride's prankster sense of humour, or a cutthroat competitive nature that flew in the face of female solidarity and sisterhood. 'She didn't leave tell all diaries or an audio journal of how she was feeling in every single moment. So we're left to interpret later on what her choices were, and why she did what she did.' Costantini also points to Ride's five-year marriage to fellow astronaut Steve Hawley. The union in retrospect can be seen as a betrayal of who she was, and the LGTBQ+ movement that she never publicly aligned with. But it was also a necessary and sacrificial career move to make her dream possible, deflecting any suspicions about sexual orientation while making Ride a more ideal candidate to make history and inspire young women. 'People didn't like women in space,' says Costantini. 'And they especially didn't like single women in space. Some of the male astronauts were, like: 'Well, it was a good look for her not to be single and in space.'' When Ride does climb above the atmosphere on her historic mission, there's a cathartic moment where the tense conflicts within her – or put upon her – are either resolved or abandoned, if only temporarily. Related: Liza: A Truly Terrific Absolutely True Story review – dazzling glamour and true grit 'I loved being weightless,' says Ride, while in space, her recorded words packing new mean considering all the burdens we now understand. 'It's a feeling of freedom.' 'She escaped Earth's orbit – Earth's gravity – metaphorically too,' says Costantini, on that pivotal moment in American history and Ride's personal life. 'Looking at the Earth from space, she started to, for the first time, really think about the imaginary lines that we have. She was struck by the fact that all these countries have known borders around them. These are human constructions. As Tam says in the film, the lines between genders, the lines between race, the lines between countries, who we're allowed to love, those are meaningless constructs. 'Space was transformative for her. When she came back to Earth, she finally allowed herself to be who she really is, and love who she really loved.' Sally premieres on National Geographic on 16 June and is available on Hulu and Disney+ on 17 June
